Trakm8 has named Nickie Hunt-Mason as its new director of direct sales, fleet and optimisation.

The appointment is part of the company’s growth strategy to meet its ambition target of one million telematics devices reporting to its servers by the end of 2020.

Currently the company has more than 250,000 units in play.

John Watkins, executive chairman of Trakm8, said: “We are delighted to welcome Nickie to Trakm8. She brings with her a wealth of experience in telematics, and has a proven track record in business development with major fleets. She has all the right attributes to take our fleet business to the next level.”

Hunt-Mason’s role is to enhance direct sales and the B2B team for Trakm8’s end-to-end fleet management solution. This includes telematics, driver behaviour analytics, route optimisation and fleet scheduling, vehicle cameras, and integration with third party solutions such as ePod.

“Trakm8 goes beyond traditional telematics to offer fleets a total mobility solution, which is a great USP for us. Fleet managers and transport operators are increasingly telling us that they want to streamline their supply chain to improve efficiencies and ROI through data insights. Trakm8’s end-to-end offering, coupled with its extensive experience of integrating with third-party systems and its UK manufacturing capability, places us in a very strong position to fulfil those requirements.

“We continue to grow the sales team and are actively recruiting now to prepare us for our next growth phase. Trakm8 has a reputation for developing long-term, sustainable relationships by truly listening to its customers and delivering solutions that are right for their organisation. I am confident that our unique and compelling offering will win us significant new business going forward,” said Hunt-Mason.

In November, the company revealed a “disappointing” set of half year results, with revenues down by 38% to £8.8 million.

Its financial report also shows that last year’s pre-tax profit of £120,000 is now reported as a £2.9m loss.